Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis

BACKGROUND AND OBJECTIVE: Indacaterol/glycopyrronium (IND/GLY) 110/50 μg once daily (q.d.) has demonstrated greater improvements in lung function, patient‐reported outcomes and lower exacerbation rates versus mono long‐acting muscarinic antagonists (LAMA) in chronic obstructive pulmonary disease (CO...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Respirology
Autors principals: Muro, Shigeo, Yoshisue, Hajime, Kostikas, Konstantinos, Olsson, Petter, Gupta, Pritam, Wedzicha, Jadwiga A.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7155057/
https://ncbi.nlm.nih.gov/pubmed/31339215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/resp.13651
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars